Pharma Pipeline Pro Forma
Healthcare Excel Template (Free Download)
Convert clinical-stage assumptions, probability of success, R&D spend, and commercial forecasts into a risk-adjusted pharmaceutical pipeline pro forma.
professionals from Deloitte
About this pro forma
This pro forma presents the projected financial output of a pharmaceutical pipeline spanning clinical progression, development spend, launch timing, and commercial lifecycle. Stage-specific probabilities flow through risk-adjusted cash flows, while peak sales, exclusivity, generic entry, R&D, SG&A, and funding assumptions shape value.
Use it to compare candidates, plan financing milestones, and assess in-licensing or acquisition opportunities. The Excel model performs the probability and discounting mechanics; the pro forma makes projected pipeline value and cash requirements easier to review.
What every model includes
Live formulas, no hardcoded values
Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.
All assumptions in one tab
Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.
Statements always balancing
For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.
Distinct schedules for clarity
Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.
No hidden macros or external links
There are no unexplained external workbook links or macros to undermine auditability or portability.
Changes flow through the model
Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.
What's inside the Pharma Pipeline Pro Forma
- Clinical phase timeline and probability-of-success forecast
- Phase-by-phase R&D cost and cash burn projection
- Peak sales, market penetration, and launch ramp output
- Patent exclusivity, generic entry, and revenue decline schedule
- Risk-adjusted NPV by compound and therapeutic area
- Funding rounds, dilution, runway, and per-share valuation outputs
Formatted to IB standards
Named theme colors repaint the whole workbook in one click, on top of an investment-banking structure with clear input, output, and cross-sheet reference styling - brand-ready, institutional-grade, and fully auditable.
Created by ex-finance professionals
Hey, I’m Alex and I created Finamodel.
Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.
Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.
I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.
Having a template library on hand cuts a first build from hours to minutes.
Need help finding your model? You’ll find me in the Finamodel app!
Frequently asked
What is a pharma pipeline pro forma?+
It is a projected financial view of drug candidates, development costs, commercial revenues, risk-adjusted cash flows, and pipeline value.
How does it reflect clinical risk?+
Stage-specific success probabilities are applied to candidate cash flows to produce risk-adjusted valuation outputs.
Can it show patent cliffs?+
Yes. Exclusivity periods, generic entry, and post-exclusivity revenue declines can be projected by candidate.
Who can use it?+
Biotech founders, pharma finance teams, investors, analysts, and M&A teams can adapt it for pipeline decisions.
Have more financial modelling questions? Contact us
Related pro formas
Medtech Pro Forma
Revenue and profitability model for medical device companies including R&D, regulatory, manufacturing, and distribution.
Biotech Licensing Pro Forma
Pharmaceutical and biotech licensing deal valuation.
Venture Capital Pro Forma
Model VC fund cash flows, distributed returns, and IRR by vintage year and exit scenario.
Gym Pro Forma
Operating model for fitness franchises and independent gyms including membership revenue, class scheduling, and facility utilization.
